Revolutionizing SFA Therapy with Drug-Elution Revolutionizing SFA Therapy with Drug-Elution
Anchor component is added but not authored

About Drug-Eluting Technologies

As the only company to offer both a drug-eluting stent and a drug-coated balloon, Boston Scientific is fundamentally changing the treatment of SFA lesions with innovative technologies designed to deliver better clinical outcomes and improve patients' lives.

Juan Granada, MD

Executive Director CRF Skirball Center for Innovation

"This is a new era. The local drug delivery era for peripheral vascular interventions is here and I think it's here to stay. I don't think we're going to go back again."

Renu Virmani, MD

President CV Path Institute

"The longer you have kept the drug in, the better the results are going to be… it's a delicate balance of the total amount of drug you deliver, and for how long you deliver."

Products Overview

Drug-Eluting Vascular Stent System

The Eluvia Drug-Eluting Stent delivers unprecedented results in the SFA through its unique SUSTEND™ drug-delivery technology.

Paclitaxel-Coated PTA Balloon Catheter

The Ranger Drug Coated balloon has been designed to provide consistent and predictable drug delivery through efficient drug transfer and a strong coating integrity.

Eluvia Data Eluvia Data
Ranger Data Ranger Data